PIGU-MAP1LC3A Fusion FISH Probe
The PIGU-MAP1LC3A Fusion FISH Probe is used to confirm a fusion of the PIGU and MAP1LC3A genes. The fusion of the PIGU and MAP1LC3A genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PIGU-MAP1LC3A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PIGU-MAP1LC3A-20-AQAQ | 20 (40 μL) | 200 μL |
|
MAP1LC3A Gene Summary
MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis. [provided by RefSeq, Feb 2012]
Gene Name: Microtubule Associated Protein 1 Light Chain 3 Alpha
Chromosome: CHR20: 33134691 -33148149
Locus: 20q11.22
PIGU Gene Summary
The protein encoded by this gene shares similarity with Saccharomyces cerevisiae Cdc91, a predicted integral membrane protein that may function in cell division control. The protein encoded by this gene is the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins. [provided by RefSeq, Jul 2008]
Gene Name: Phosphatidylinositol Glycan Anchor Biosynthesis Class U
Chromosome: CHR20: 33148345 -33265089
Locus: 20q11.22
Gene Diseases
The PIGU MAP1LC3A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|